Search clinical trials for: Ibrutinib Imbruvica
Total 382 results
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingWaldenstrom Macroglobulinemia | Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom MacroglobulinemiaUnited States
-
Mayo ClinicActive, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Prof. Dr. Clemens SchmittCharite University, Berlin, Germany; Janssen-Cilag Ltd.Active, not recruitingDiffuse Large B Cell LymphomaGermany
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Andrew RezvaniNational Institutes of Health (NIH); Pharmacyclics LLC.CompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
TG Therapeutics, Inc.Terminated
-
BeiGeneCompletedWaldenström's MacroglobulinemiaUnited States, Spain, Australia, France, United Kingdom, Germany, Netherlands, Czechia, Italy, Poland, Belgium, Greece, Sweden
-
Northwell HealthPharmacyclics LLC.TerminatedRichter SyndromeUnited States
-
Michael ChoiPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Oncternal Therapeutics, IncPharmacyclics LLC.WithdrawnImmune System Diseases | Lymphoma | Lymphoma, B-Cell | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Graft Versus Host DiseaseUnited States, Australia, Austria, Canada, China, Croatia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Singapore, Spain, Taiwan
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterAmgenTerminatedHematopoietic/Lymphoid Cancer | Richter's TransformationUnited States
-
Inhye AhnBayerWithdrawnChronic Lymphocytic Leukemia (CLL)
-
AbbVieCompletedLeukemia | Cancer | T-cell Prolymphocytic Leukemia (T-PLL)United States, Australia, Austria, Finland, France, Germany, Italy, Netherlands, United Kingdom
-
Dana-Farber Cancer InstitutePharmacyclics LLC.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
German CLL Study GroupJanssen-Cilag Ltd.CompletedChronic Lymphocytic LeukemiaGermany
-
TG Therapeutics, Inc.CompletedMantle Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
Hackensack Meridian HealthJanssen Scientific Affairs, LLC; Genentech, Inc.Active, not recruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent B-Cell Prolymphocytic Leukemia | Refractory B-Cell Prolymphocytic LeukemiaUnited States
-
PETHEMA FoundationActive, not recruitingChronic Lymphocytic LeukemiaSpain
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | B-Cell Neoplasm | Small Lymphocytic Lymphoma | Asymptomatic COVID-19 Infection Laboratory-Confirmed | Symptomatic COVID-19 Infection Laboratory-Confirmed | Chronic Lymphocytic Leukemia/Small...United States
-
Incyte CorporationCompletedB-cell LymphomaUnited States, Spain, Italy
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLC; Janssen Scientific Affairs, LLCCompletedColorectal Cancer | Colon Cancer | Colorectal Carcinoma | Colon DiseaseUnited States
-
AbbVieJanssen Research & Development LLC; Pharmacyclics LLC (An AbbVie Company)CompletedCoronaVirus Induced Disease-2019 (COVID-19)United States
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Israel
-
Jennifer WoyachKaryopharm Therapeutics IncActive, not recruitingRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Swiss Group for Clinical Cancer ResearchEuropean Mantle Cell Lymphoma NetworkTerminatedMantle Cell LymphomaItaly, Germany, Switzerland
-
National Heart, Lung, and Blood Institute (NHLBI)TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Leukemia (SLL)United States
-
University of California, DavisPharmacyclics LLC.CompletedMetastatic Renal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityCompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Kerry RogersJanssen Research & Development, LLCWithdrawnChronic Lymphocytic Leukemia | Loss of Chromosome 17p
-
Brian JonasNational Cancer Institute (NCI); Celgene; Pharmacyclics LLC.CompletedPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Therapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic SyndromeUnited States
-
Steven E. CoutreCompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Aptevo TherapeuticsTerminatedChronic Lymphocytic Leukemia | Peripheral T-cell LymphomaUnited States
-
Ludwig-Maximilians - University of MunichHoffmann-La Roche; Janssen-Cilag G.m.b.HActive, not recruitingIndolent Non-Hodgkin LymphomaGermany
-
Ruijin HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
Grupo Cooperativo de Hemopatías MalignasCompletedB-Cell Chronic Lymphocytic Leukemia | B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)Mexico
-
Pharmacyclics LLC.CompletedMetastatic Pancreatic AdenocarcinomaSpain, Italy, Korea, Republic of, United States, Belgium, United Kingdom, Germany, France
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.TerminatedHigh Risk Smoldering Multiple MyelomaUnited States
-
Samsung Medical CenterCompletedEpstein-Barr Virus-positive Diffuse Large B-cell LymphomaKorea, Republic of
-
H. Lee Moffitt Cancer Center and Research InstitutePharmacyclics LLC.CompletedCarcinoid Tumors | Pancreatic NETUnited States
-
Johnson & Johnson Private LimitedCompletedLymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-CellIndia
-
Pharmacyclics Switzerland GmbHJanssen Research & Development, LLCCompletedMultiple MyelomaSpain, Germany, Turkey, Greece, Italy, Czechia
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyWithdrawnWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia
-
Eugene NikitinUnknownAIHA - Warm Autoimmune Hemolytic AnemiaRussian Federation
-
Janssen Research & Development, LLCCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain, Poland